|Generic Name||Brand Name|
Paclitaxel interferes with the cancer cell's ability to reproduce. Paclitaxel is an intravenous (IV) medicine. The type and extent of a cancer determines the exact dose and schedule of administering this medicine.
Paclitaxel slows or stops the growth and spread of cancer cells in the body. It is commonly used to treat breast cancer, ovarian cancer, cervical cancer, testicular cancer, Kaposi's sarcoma, bladder cancer, and non–small cell lung cancer.
Paclitaxel is an effective antitumor medicine. But the type and extent of a cancer determines how effectively this medicine slows or stops the growth of cancer cells in the body.
Possible serious side effects of paclitaxel include:
Less serious side effects are more common and may include:
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Paclitaxel should be administered only under the supervision of a medical oncologist.
You may not be able to become pregnant or father a child after taking this medicine. Discuss fertility with your doctor before starting treatment.
Paclitaxel can cause birth defects. Do not use this medicine if you are pregnant or wish to become pregnant or to father a child while you are taking it.
Other Works Consulted
- Abramowicz M (2003). Treatment guidelines: Drugs of choice for cancer. Medical Letter on Drugs and Therapeutics, 1(7): 41–52.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.